메뉴 건너뛰기




Volumn 47, Issue 3, 2014, Pages 81-83

Reduction of parkinsonism and psychosis with mirtazapine: A case report

Author keywords

hallucinations; Lewy bodies; mirtazapine; Parkinson's disease; psychosis; SSRI

Indexed keywords

AMANTADINE; BENSERAZIDE PLUS LEVODOPA; CARBIDOPA PLUS ENTACAPONE PLUS LEVODOPA; CLONAZEPAM; CLOZAPINE; MIRTAZAPINE; PERGOLIDE; QUETIAPINE; RIVASTIGMINE; ROPINIROLE; SELEGILINE; HISTAMINE H1 RECEPTOR ANTAGONIST; MIANSERIN;

EID: 84901381329     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0034-1367014     Document Type: Article
Times cited : (24)

References (18)
  • 1
    • 0014082977 scopus 로고
    • Parkinsonism: Onset, progression and mortality
    • Hoehn N. M., Yahr M. D. Parkinsonism: onset, progression and mortality. Neurology: 1967; 17 427 442
    • (1967) Neurology , vol.17 , pp. 427-442
    • Hoehn, N.M.1    Yahr, M.D.2
  • 2
    • 0037105035 scopus 로고    scopus 로고
    • The effects of mirtazapine on sleep: A placebo controlled, double-blind study in young healthy volunteers
    • Aslan S., Isik E., Cosar B. The effects of mirtazapine on sleep: a placebo controlled, double-blind study in young healthy volunteers. Sleep: 2002; 25 677 679 (Pubitemid 34977508)
    • (2002) Sleep , vol.25 , Issue.6 , pp. 677-679
    • Aslan, S.1    Isik, E.2    Cosar, B.3
  • 3
    • 84861652848 scopus 로고    scopus 로고
    • Increased levels of 5-HT1A receptor binding in ventral visual pathways in Parkinson's disease
    • Huot P., Johnston T. H., Visanji N. P. et al. Increased levels of 5-HT1A receptor binding in ventral visual pathways in Parkinson's disease. Mov Disord: 2012; 27 735 742
    • (2012) Mov Disord , vol.27 , pp. 735-742
    • Huot, P.1    Johnston, T.H.2    Visanji, N.P.3
  • 4
    • 0036125178 scopus 로고    scopus 로고
    • 2C receptors in the control of brain dopaminergic function
    • DOI 10.1016/S0091-3057(01)00705-5, PII S0091305701007055
    • Matteo V., di Cacchio M., Di Giulio C. et al. Role of serotonin (2C) receptors in the control of brain dopaminergic function. Pharmacol Biochem Behav: 2002; 71 727 734 (Pubitemid 34219223)
    • (2002) Pharmacology Biochemistry and Behavior , vol.71 , Issue.4 , pp. 727-734
    • Di Matteo, V.1    Cacchio, M.2    Di Giulio, C.3    Esposito, E.4
  • 5
    • 84961395178 scopus 로고    scopus 로고
    • A case in which mirtazapine reduced auditory hallucinations in a patient with Parkinson disease
    • Nagata T., Shinagawa S., Tagai K. et al. A case in which mirtazapine reduced auditory hallucinations in a patient with Parkinson disease. Int Psychogeriatr: 2012; 30 1 3
    • (2012) Int Psychogeriatr , vol.30 , pp. 1-3
    • Nagata, T.1    Shinagawa, S.2    Tagai, K.3
  • 6
    • 0031467188 scopus 로고    scopus 로고
    • Psychosis during chronic levodopa therapy triggered by the new antidepressive drug mirtazapine
    • Normann C., Hesslinger B., Frauenknecht S. et al. Psychosis during chronic levodopa therapy triggered by the new antidepressive drug mirtazapine. Pharmacopsychiatry: 1997; 30 263 265 (Pubitemid 28006079)
    • (1997) Pharmacopsychiatry , vol.30 , Issue.6 , pp. 263-265
    • Normann, C.1    Hesslinger, B.2    Frauenknecht, S.3    Berger, M.4    Walden, J.5
  • 7
    • 84884237905 scopus 로고    scopus 로고
    • Parkinson disease psychosis: Update
    • Friedman J. H. Parkinson disease psychosis: Update. Behav Neurol: 2013; 27 469 477
    • (2013) Behav Neurol , vol.27 , pp. 469-477
    • Friedman, J.H.1
  • 8
    • 69549111221 scopus 로고    scopus 로고
    • Management of non-motor complications in Parkinson's disease
    • Fujimoto K. Management of non-motor complications in Parkinson's disease. J Neurol: 2009; 256 03 299 305
    • (2009) J Neurol , vol.256 , Issue.3 , pp. 299-305
    • Fujimoto, K.1
  • 9
    • 0028899702 scopus 로고
    • Mianserin treatment of patients with psychosis induced by antiparkinsonian drugs
    • Ikeguchi K., Kuroda A. Mianserin treatment of patients with psychosis induced by antiparkinsonian drugs. Eur Arch Psychiatry Clin Neurosci: 1995; 244 320 324
    • (1995) Eur Arch Psychiatry Clin Neurosci , vol.244 , pp. 320-324
    • Ikeguchi, K.1    Kuroda, A.2
  • 10
    • 0042161639 scopus 로고    scopus 로고
    • Inhibiteurs de la recapture de la sérotonine dans la dépression de la maladie d'Alzheimer et autres démences
    • Lebert F. Serotonin reuptake inhibitors in depression of 'Alzheimer's disease and other dementias. [Article in French] Presse Med: 2003; 32 1181 1186 (Pubitemid 36987898)
    • (2003) Presse Medicale , vol.32 , Issue.25 , pp. 1181-1186
    • Lebert, F.1
  • 11
    • 0032885118 scopus 로고    scopus 로고
    • Dementia with Lewy bodies: Review and pharmacotherapeutic implications
    • DOI 10.1592/phco.19.10.795.31555
    • Rojas-Fernandez C. H., MacKnight C. Dementia with Lewy bodies: review and pharmacotherapeutic implications. Pharmacotherapy: 1999; 19 795 803 (Pubitemid 29415834)
    • (1999) Pharmacotherapy , vol.19 , Issue.7 , pp. 795-803
    • Rojas-Fernandez, C.H.1    MacKnight, C.2
  • 12
    • 0030939443 scopus 로고    scopus 로고
    • Drug treatment in Lewy body dementia
    • Geroldi C., Frisoni G. B., Bianchetti A. et al. Drug treatment in Lewy body dementia. Dement Geriatr Cogn Disord: 1997; 8 188 197 (Pubitemid 27183225)
    • (1997) Dementia and Geriatric Cognitive Disorders , vol.8 , Issue.3 , pp. 188-197
    • Geroldi, C.1
  • 13
    • 28544442286 scopus 로고    scopus 로고
    • Neuroscientific Basis and Practical Applications Cambridge University Press
    • Stahl S. M. Stahl's Essential Psychopharmacology. Neuroscientific Basis and Practical Applications. Cambridge University Press: 2011
    • (2011) Stahl's Essential Psychopharmacology
    • Stahl, S.M.1
  • 15
    • 0038485934 scopus 로고    scopus 로고
    • Mirtazapine in essential tremor: A double-blind, placebo-controlled pilot study
    • DOI 10.1002/mds.10371
    • Pahwa R., Lyons K. E. Mirtazapine in essential tremor: a double-blind, placebo-controlled pilot study. Mov Disord: 2003; 18 584 587 (Pubitemid 36656544)
    • (2003) Movement Disorders , vol.18 , Issue.5 , pp. 584-587
    • Pahwa, R.1    Lyons, K.E.2
  • 16
    • 33646020370 scopus 로고    scopus 로고
    • Mirtazapine in the treatment of essential tremor: An open-label, observer-blind study
    • Uccellini D., Grampa G., Spina I. et al. Mirtazapine in the treatment of essential tremor: an open-label, observer-blind study. Neuropsychiatric Disease and Treatment: 2006; 95 100
    • (2006) Neuropsychiatric Disease and Treatment , pp. 95-100
    • Uccellini, D.1    Grampa, G.2    Spina, I.3
  • 17
    • 0033595471 scopus 로고    scopus 로고
    • Mirtazapine treats resting tremor, essential tremor, and levodopa- induced dyskinesias
    • Pact V., Giduz T. Mirtazapine treats resting tremor, essential tremor, and levodopa-induced dyskinesias. Neurology: 1999; 53 1154 (Pubitemid 29442147)
    • (1999) Neurology , vol.53 , Issue.5 , pp. 1154
    • Pact, V.1    Giduz, T.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.